This content is relevant for:Pharmaceuticals / Medical Biotechnology / Medical Technologies / Healthcare
In the global race to deal with Covid-19, Germany’s extensive network of pharmaceutical companies are involved in major international collaborations and are benefiting from generous government support. German pharma is driving digitalization forward.
Germany is at the forefront of attempts to develop a coronavirus vaccine, and a number of German companies are searching for ways to treat SARS-CoV-2. At the same time, the pandemic is changing the face of the pharmaceutical sector in Germany.